ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Hydroxychloroquine Sulfate Tablets
News »
latest
by relevance
Stride Arcolab gets tentative USFDA nod
May 17, 2010 at 14:43 | Source:
Reuters
Strides Arcolab has received tentative US FDA approval for its generic drug abacavir sulfate in tablet form, the drug regulator's website showed on Monday.
US FDA gives Glenmark 60 days to stop pain drug production
Apr 01, 2009 at 09:00 | Source:
CNBC-TV18
The US FDA has issues a warning letter to Indian drug maker Glenmark Pharma to stop manufacturing Morphine Sulfate tablets and solutions. Morphine Sulfate is generic prescription for pain management. The US FDA has given Glenmrk Pharma 60 days to stop manufacturing these products and given distributors 90 days to stop shipping existing products.
Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab
Dec 22, 2008 at 13:33
Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market fixed dosed combination Abacavir Sulfate / Lamivudine Tablets 60/30mg from the US Food & Drug Administration
Glenmark gets approval for Ranitidine tablets from US FDA
Nov 21, 2008 at 12:23
Glenmark Generics Ltds, US subsidiary (GGI) has received ANDA approval from the United States Food and Drug Administration for Ranitidine 150 mg and 300 mg tablets and will soon commence marketing and distribution of these products in the U.S. market.
Aurobindo Pharma gets approval for Abacavir Sulfate tabs
Sep 17, 2008 at 11:51
Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate tablets 60mg from the US Food & Drug Administration
Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab
Sep 08, 2008 at 16:01
Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate / Lamivudine tablets 600mg/300mg from the US Food & Drug Administration
Stride Arcolab gets tentative USFDA nod
May 17, 2010 at 14:43 | Source:
Reuters
Strides Arcolab has received tentative US FDA approval for its generic drug abacavir sulfate in tablet form, the drug regulator's website showed on Monday.
US FDA gives Glenmark 60 days to stop pain drug production
Apr 01, 2009 at 09:00 | Source:
CNBC-TV18
The US FDA has issues a warning letter to Indian drug maker Glenmark Pharma to stop manufacturing Morphine Sulfate tablets and solutions. Morphine Sulfate is generic prescription for pain management. The US FDA has given Glenmrk Pharma 60 days to stop manufacturing these products and given distributors 90 days to stop shipping existing products.
Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab
Dec 22, 2008 at 13:33
Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market fixed dosed combination Abacavir Sulfate / Lamivudine Tablets 60/30mg from the US Food & Drug Administration
Glenmark gets approval for Ranitidine tablets from US FDA
Nov 21, 2008 at 12:23
Glenmark Generics Ltds, US subsidiary (GGI) has received ANDA approval from the United States Food and Drug Administration for Ranitidine 150 mg and 300 mg tablets and will soon commence marketing and distribution of these products in the U.S. market.
Aurobindo Pharma gets approval for Abacavir Sulfate tabs
Sep 17, 2008 at 11:51
Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate tablets 60mg from the US Food & Drug Administration
Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab
Sep 08, 2008 at 16:01
Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate / Lamivudine tablets 600mg/300mg from the US Food & Drug Administration
Videos »
US FDA gives Glenmark 60 days to stop pain drug production
more »
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window